Our Publications Visit PubMed for our journal articles 
|
|
|
For women showing the first signs of recurrent cervical cancer, our researchers are working to develop better chemotherapy agents, including novel investigational drugs available only through clinical trials at Memorial Sloan-Kettering. We also have experts devoted to the detection and management of rarer cervical cancers.
In addition, we are committed to clinical research that will improve both survival and quality of life for women with cervical cancer.